Estats Units - anglès - NLM (National Library of Medicine)

pinnacle biologics, inc. - porfimer sodium (unii: y3834sik5f) (porfimer - unii:m15h03k69b) - porfimer sodium 75 mg in 31.8 ml - photofrin ® is indicated for the palliation of patients with completely obstructing esophageal cancer, or of patients with partially obstructing esophageal cancer who, in the opinion of their healthcare provider, cannot be satisfactorily treated with nd:yag laser therapy. photofrin is indicated for the treatment of microinvasive endobronchial non-small-cell lung cancer (nsclc) in patients for whom surgery and radiotherapy are not indicated. photofrin is indicated for the reduction of obstruction and palliation of symptoms in patients with completely or partially obstructing endobronchial nsclc. photofrin is indicated for the ablation of high-grade dysplasia in barrett’s esophagus patients who do not undergo esophagectomy. - photofrin is contraindicated in patients with porphyria. - photodynamic therapy (pdt) is contraindicated in patients with an existing tracheoesophageal or bronchoesophageal fistula. - pdt is contraindicated in patients with tumors eroding into a major blood vessel. - pdt is

Unió Europea - anglès - EMA (European Medicines Agency)

pinnacle biologics b.v.  - porfimer sodium - barrett esophagus - antineoplastic agents - photodynamic therapy (pdt) with photobarr is indicated for: ablation of high-grade dysplasia (hgd) in patients with barrett's oesophagus (bo)

Estats Units - anglès - NLM (National Library of Medicine)

axcan scandipharm inc. - porfimer sodium (unii: y3834sik5f) (porfimer - unii:m15h03k69b) - injection, powder, for solution - 2.5 mg in 1 ml - photodynamic therapy with photofrin® is indicated for: - palliation of patients with completely obstructing esophageal cancer, or of patients with partially obstructing esophageal cancer who, in the opinion of their physician, cannot be satisfactorily treated with nd:yag laser therapy. - reduction of obstruction and palliation of symptoms in patients with completely or partially obstructing endobronchial non-small-cell lung cancer (nsclc). - treatment of microinvasive endobronchial nsclc in patients for whom surgery and radiotherapy are not indicated. - ablation of high-grade dysplasia in barrett’s esophagus patients who do not undergo esophagectomy. photofrin® is contraindicated in patients with porphyria or in patients with known allergies to porphyrins. photodynamic therapy is contraindicated in patients with an existing tracheoesophageal or bronchoesophageal fistula. photodynamic therapy is contraindicated in patients with tumors eroding into a major blood vessel. photodynamic therapy is not

Canadà - anglès - Health Canada

concordia laboratories inc - porfimer sodium - powder for solution - 75mg - porfimer sodium 75mg - antineoplastic agents

Canadà - anglès - Health Canada

concordia laboratories inc - porfimer sodium - powder for solution - 15mg - porfimer sodium 15mg - antineoplastic agents

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

axcan pharma international b.v. - porfimer sodium - pdr for soln for injection - 2.5 mg/ml

Filipines - anglès - FDA (Food And Drug Administration)

united laboratories, inc. - iron , folic acid , vitamin b -complex - tablet - each tablet contains: ferrous fumarate (elemental iron equivalent, 98.6 mg) 300 mg folic acid 500 mcg thiamine mononitrate (vitamin b1) 5 mg pyridoxine hydrochloride (vitamin b6) 5 mg cyanocobalamin (vitamin b12) 15 mcg

Filipines - anglès - FDA (Food And Drug Administration)

unilab, inc.; importer: n/a; distributor: n/a - thiamine mononitrate (vitamin b1) , pyridoxine hydrochloride (vitamin b6) , folic acid (vitamin b9) , cyanocobalamin (vitamin b12) , iron - film-coated tablet - each film-coated tablet contains: iron, elemental (as ferrous fumarate 300 mg) 98.6 mg; folic acid 500 mcg; thiamine mononitrate (vitamin b1) 5 mg; pyridoxine hydrochloride (vitamin b6) 5 mg; cyanocobalamin (vitamin b12) 15 mcg

Filipines - anglès - FDA (Food And Drug Administration)

multicare pharmaceuticals phils inc - ferrous sulfate - sustained-release tablet - 310mg